Alerts
AMR Plans Without Money
Twenty-seven Asia-Pacific countries have antimicrobial-resistance action plans. Nearly half are still not fully costed, and only eight countries report financing their AMR activities entirely from domestic sources. The region is getting better at writing the plans. It has not yet solved how to pay for them.
America Has Already Passed Last Year’s Measles Total.
ctDNA Is Becoming a Surveillance Policy, Not Just a Test
345 Salmonella Cases Later, The Supply Chain Is Still Being Reconstructed.
AI Wants to Choose Pancreatic Chemo
ALS Biomarkers Are Entering the Approval Fight
GLP-1 drugs can reduce adolescent obesity. Who will pay for years of treatment?
Stroke Recovery Needs More Than Scans and Scores
The Cyclospora Test Was Wrong. Public Trust Cannot Be
A Breast-Cancer Warning Is Hiding in Aggregated Data
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.